IKT Inhibikase Therapeutics beats Q4 2025 loss estimates shares post modest gains following earnings release CMIIW Columbus Cap outlines forwardlooking strategic growth plans as latest quarterly earnings metrics remain undisclosed NNE Nano posts narrower than expected Q1 2026 loss shares climb 428 percent on positive investor sentiment How BIP Perp BIPI pricing changes flow through to earnings